Akanda (AKAN) Retained Earnings (2020 - 2025)
Akanda's (AKAN) quarterly Retained Earnings came in at -$2.3 million in Q4 2025, down 43.31% year-on-year from -$4.1 million in Q4 2024, and down 68487.69% quarter-over-quarter from $3370.0 in Q2 2025.
Akanda (AKAN) Retained Earnings (2020 - 2025) Analysis & Trends
Akanda's Retained Earnings history runs 6 years deep, the most recent figure standing at -$2.3 million for Q4 2025.
- On a quarterly basis, Retained Earnings fell 43.31% year-over-year to -$2.3 million in Q4 2025; TTM through Dec 2025 was -$2.3 million, a 43.31% decrease from a year earlier, with the FY2025 full-year figure at -$2.3 million, down 43.31% from the prior year.
- Retained Earnings eased to -$2.3 million in Q4 2025 per AKAN's latest filing, from $3370.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $24423.0 in Q2 2024 and bottomed at -$21.1 million in Q4 2022.
- The 5-year median for Retained Earnings is $3370.0 (2025), against an average of -$4.2 million.
- Across the five-year window, Retained Earnings soared 100.1% in 2023 and sank 7738.92% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$13.3 million in 2021, then tumbled by 58.63% to -$21.1 million in 2022, then surged by 100.1% to $21053.0 in 2023, then sank by 7738.92% to -$1.6 million in 2024, then sank by 43.31% to -$2.3 million in 2025.
- Per Business Quant, the three latest AKAN Retained Earnings figures stand at -$2.3 million (Q4 2025), $3370.0 (Q2 2025), and -$1.6 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | -2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.30 Mn |
| Jun 30, 2025 | 3,370.00 |
| Dec 31, 2024 | -1.61 Mn |
| Jun 30, 2024 | 24,423.00 |
| Dec 31, 2023 | 21,053.00 |
| Jun 30, 2023 | 21,053.00 |
| Dec 31, 2022 | -21.09 Mn |
| Jun 30, 2022 | 21,051.00 |
| Dec 31, 2021 | -13.29 Mn |
| Dec 31, 2020 | -5.16 Mn |